Cancer/ ESMO2016/ R&D/ Views and analysis Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle Andrew McConaghie breakthrough, chemotherapy, ESMO, lung, Merck, Oncology, pembro, pembrolizumab, small cell, treatment 0 Comment Merck unveils impressive data on Keytruda, trumping BMS’ Opdivo Share X Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle https://pharmaphorum.com/esmo-2016/eye-esmo-day-three-merck-co-wins-big-lung-cancer-battle/